Benutzer: Gast  Login
Titel:

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Marconi, Vincent C; Ramanan, Athimalaipet V; de Bono, Stephanie; Kartman, Cynthia E; Krishnan, Venkatesh; Liao, Ran; Piruzeli, Maria Lucia B; Goldman, Jason D; Alatorre-Alexander, Jorge; de Cassia Pellegrini, Rita; Estrada, Vicente; Som, Mousumi; Cardoso, Anabela; Chakladar, Sujatro; Crowe, Brenda; Reis, Paulo; Zhang, Xin; Adams, David H; Ely, E Wesley; Ahn, Mi-Young; Akasbi, Miriam; Alatorre-Alexander, Jorge; Altclas, Javier David; Ariel, Federico; Ariza, Horacio Alberto; Atkar, Chandrasekhar;...     »
Zeitschriftentitel:
The Lancet Respiratory Medicine
Jahr:
2021
Band / Volume:
9
Heft / Issue:
12
Seitenangaben Beitrag:
1407-1418
Volltext / DOI:
doi:10.1016/s2213-2600(21)00331-3
Verlag / Institution:
Elsevier BV
E-ISSN:
2213-2600
Publikationsdatum:
01.12.2021
 BibTeX